Novel Experimental Therapeutic Targets and Strategies for Brain Tumors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 5752
Special Issue Editors
Interests: glioblastoma; brain tumors
Special Issue Information
Dear Colleagues,
Brain cancers are one of the most deadly tumors with poor prognoses. The 5-year survival rate for people with a cancerous brain or CNS tumor in the USA is about 36%, despite the advances in surgical resection and ionizing radiation +/- chemotherapy. Since treating malignant brain tumors is frustratingly ineffective, it is imperative to identify novel therapeutic targets and approaches, and develop more effective combinational therapies.
This Special Issue focuses on the identification of new experimental therapeutic targets and/or the development of new therapeutic strategies for adult and pediatric brain tumors. We are particularly (but not exclusively) interested in drugs and approaches that sensitize tumors to standard-of-care radiotherapy, chemotherapy, and immunotherapy, as well as clinical trials with small molecule inhibitors and other drugs. We are also seeking articles that describe novel combinational therapies and innovative drug delivery approaches. We are pleased to invite you to submit original research articles and reviews on the above areas of research. We hope that this Special Issue will enhance our understanding of brain tumors and the development and testing of new therapies. We look forward to receiving your contributions.
Dr. Yunqing Li
Prof. Dr. Roger Abounader
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain tumors
- glioma
- glioblastoma
- medulloblastoma
- radiotherapy
- chemotherapy
- immunotherapy
- combination therapy
- microRNAs
- oncogene signaling pathways
- epigenetic regulation
- metabolic regulation
- nanotechnology
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.